Fuminori Hirano

1.6k total citations
23 papers, 742 citations indexed

About

Fuminori Hirano is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Fuminori Hirano has authored 23 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Fuminori Hirano's work include NF-κB Signaling Pathways (6 papers), Drug Transport and Resistance Mechanisms (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Fuminori Hirano is often cited by papers focused on NF-κB Signaling Pathways (6 papers), Drug Transport and Resistance Mechanisms (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Fuminori Hirano collaborates with scholars based in Japan, Germany and United Kingdom. Fuminori Hirano's co-authors include Isao Makino, Claus Scheidereit, Hirotoshi Tanaka, Stéphane Ansieau, Achim Leutz, Vigo Heissmeyer, Kerstin Lehmann, Ralf Dechend, F. Gregory Wulczyn and Hiroshi Handa and has published in prestigious journals such as Molecular and Cellular Biology, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

Fuminori Hirano

21 papers receiving 734 citations

Peers

Countries citing papers authored by Fuminori Hirano

Since Specialization

Citations

This map shows the geographic impact of Fuminori Hirano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuminori Hirano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuminori Hirano more than expected).

Fields of papers citing papers by Fuminori Hirano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuminori Hirano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuminori Hirano. The network helps show where Fuminori Hirano may publish in the future.

Co-authorship network of co-authors of Fuminori Hirano

This figure shows the co-authorship network connecting the top 25 collaborators of Fuminori Hirano. A scholar is included among the top collaborators of Fuminori Hirano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuminori Hirano. Fuminori Hirano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Factors contributing to the improvement in Japanese Health Assessment Questionnaire after 3 years of treatment with abatacept in biologic-naïve rheumatoid arthritis patients: Interim results of a long-term, observational, multicentre study in Japan (ORIGAMI) 2024 ·Modern Rheumatology ·(unknown), Eiichi Tanaka, Eisuke Inoue, Naoto Tamura, Fuminori Hirano, Yoshinori Taniguchi, Hiroshi Sato, Taio Naniwa, (unknown), Tamami Yoshitama, Yuya Takakubo, Yoko Suzuki, (unknown), Katsuki Tsuritani, Shigeru Matsumoto, Hisashi Yamanaka, Masayoshi Harigai	0
2	Contribution of the factors to EuroQol 5 Dimensions in rheumatoid arthritis patients achieving low disease activity/remission with abatacept treatment: Post hoc subgroup analyses of the Japanese real-world observational ‘ORIGAMI’ study 2023 ·Modern Rheumatology ·Masayoshi Harigai, Eiichi Tanaka, Eisuke Inoue, Naoto Tamura, (unknown), (unknown), Shintaro Hirata, Fuminori Hirano, Yoshinori Taniguchi, (unknown), Masahiro Kondo, Motohiro Oribe, (unknown), (unknown), Katsuki Tsuritani, Hisashi Yamanaka	0
3	Breast arterial calcification and hypertension associated with vertebral fracture 2011 ·Geriatrics and gerontology international ·Hiroshi Wada, Fuminori Hirano, Tatsuhiko Kuroda, Masataka Shiraki	17
4	Homeobox gene CDX2 inhibits human pancreatic cancer cell proliferation by down-regulating cyclin D1 transcriptional activity 2009 ·Suizo ·(unknown), Fuminori Hirano, Kakuya Matsumoto, Kazunobu Aso, Masakazu Haneda	2
5	Homeobox Gene CDX2 Inhibits Human Pancreatic Cancer Cell Proliferation by Down-Regulating Cyclin D1 Transcriptional Activity 2008 ·Pancreas ·Kenji Takahashi, Fuminori Hirano, Kakuya Matsumoto, Kazunobu Aso, Masakazu Haneda	15
6	Chenodeoxycholic acid and taurochenodexycholic acid induce anti‐apoptotic cIAP‐1 expression in human hepatocytes 2006 ·Journal of Gastroenterology and Hepatology ·Fuminori Hirano, Masakazu Haneda, Isao Makino	28
7	Tumor necrosis factor α (TNF-α)-induced RANTES chemokine expression via activation of NF-κB and p38 MAP kinase: roles of TNF-α in alcoholic liver diseases 2003 ·Journal of Hepatology ·Fuminori Hirano, (unknown), (unknown), Isao Makino	27
8	Inhibition of TNF-α-induced RANTES expression in human hepatocyte-derived cells by fibrates, the hypolipidemic drugs 2003 ·International Immunopharmacology ·Fuminori Hirano, (unknown), Isao Makino	15
9	Fibrates suppress chenodeoxycholic acid-induced RANTES expression through inhibition of NF-κB activation 2002 ·European Journal of Pharmacology ·Yoshiko Hirano, Fuminori Hirano, Hiroshi Fujii, Isao Makino	20
10	Bile Acids Regulate RANTES Gene Expression through Its Cognate NF-κB Binding Sites 2001 ·Biochemical and Biophysical Research Communications ·Fuminori Hirano, Atsushi Kobayashi, Yoshiko Hirano, (unknown), (unknown), Isao Makino	12
11	Thrombin stimulates cell proliferation in human fibroblast-like synoviocytes in nuclear factor-kappaB activation and protein kinase C mediated pathway. 2000 ·PubMed ·Naoki Maruyama, Fuminori Hirano, Noritada Yoshikawa, Kiyoshi Migita, Katsumi Eguchi, Hirotoshi Tanaka	18
12	The Bcl-3 oncoprotein acts as a bridging factor between NF-κB/Rel and nuclear co-regulators 1999 ·Oncogene ·Ralf Dechend, Fuminori Hirano, Kerstin Lehmann, Vigo Heissmeyer, Stéphane Ansieau, F. Gregory Wulczyn, Claus Scheidereit, Achim Leutz	269
13	Alternative Splicing Variants of IκBβ Establish Differential NF-κB Signal Responsiveness in Human Cells 1998 ·Molecular and Cellular Biology ·Fuminori Hirano, Mirra Chung, Hirotoshi Tanaka, Naoki Maruyama, Isao Makino, David D. Moore, Claus Scheidereit	43
14	Functional Interference of Sp1 and NF-κB through the Same DNA Binding Site 1998 ·Molecular and Cellular Biology ·Fuminori Hirano, Hirotoshi Tanaka, Yoshiko Hirano, Masaki Hiramoto, Hiroshi Handa, Isao Makino, Claus Scheidereit	142
15	Inhibition of NF-κB-dependent transcription of human immunodeficiency virus 1 promoter by a phosphodiester compound of vitamin C and vitamin E, EPC-K1 1998 ·Immunopharmacology ·Fuminori Hirano, Hirotoshi Tanaka, Takanori Miura, Yoshiko Hirano, Kensaku Okamoto, Yuichi Makino, Isao Makino	14
16	Induction of the transcription factor AP-1 in cultured human colon adenocarcinoma cells following exposure to bile acids 1996 ·Carcinogenesis ·Fuminori Hirano, Hirotoshi Tanaka, Yuichi Makino, Kensaku Okamoto, Masaki Hiramoto, Hiroshi Handa, Isao Makino	64
17	Effects of ursodeoxycholic acid and chenodeoxycholic acid on major histocompatibility complex class I gene expression 1996 ·Journal of Gastroenterology ·Fuminori Hirano, Hirotoshi Tanaka, Yuichi Makino, Kensaku Okamoto, (unknown)	14
18	Natural course of diabetic peripheral neuropathy in spontaneous-onset diabetic Chinese hamsters 1995 ·Diabetes Research and Clinical Practice ·Fuminori Hirano, Hirotoshi Tanaka, Kensaku Okamoto, Yuichi Makino, (unknown), (unknown), (unknown), Takanori Miura, Tomofumi Tani, Isao Makino	6
19	Homologous Down-Regulation of the Glucocorticoid Receptor Down-Modulates Cellular Hormone Responsiveness in Human Histiocytic Lymphoma U937 Cells. 1994 ·Endocrine Journal ·(unknown), Hirotoshi Tanaka, Yuichi Makino, Fuminori Hirano, Hideto Akama, Shinichi Kawai, Isao Makino	6
20	Successful Treatment of Refractory Polymyositis with Pulse Intravenous Cyclophosphamide and Low-dose Weekly Oral Methotrexate Therapy. 1993 ·Internal Medicine ·Fuminori Hirano, Hirotoshi Tanaka, (unknown), (unknown), Yuichi Makino, (unknown), (unknown), Isao Makino	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact